Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
CHPT ChargePoint Holdings Inc
BASMX iShares Total U.S. Stock Market Index Fund Investor A Shares
FLNT Fluent Inc
CCXI ChemoCentryx Inc
NVTA Invitae Corp
CLNE Clean Energy Fuels Corp
IMBBY Imperial Brands PLC
T AT&T Inc
JNJ Johnson & Johnson
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of medicine to prevent and treat diseases, including human immunodeficiency virus (HIV), viral hepatitis and cancer. The Company’s products for HIV/AIDS patients include Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. Its COVID-19 product is Veklury. The products for liver diseases includes Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. The products under hematology/oncology/cell therapy include Yescarta, Tecartus, Trodelvy, and Zydelig. The other products include Letairis (ambrisentan), Ranexa (ranolazine), Cayston, Jyseleca, and AmBisome (amphotericin B liposome for injection). The Company also sells and distributes generic versions of Epclusa and Harvoni in the United States. It sells and distributes its products in the United States through the wholesale channel. It operates in more than 35 countries worldwide.

Closing Price
$61.60
Day's Change
0.51 (0.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
61.71
Day's Low
60.81
Volume
(Below Average)
Volume:
5,857,705

10-day average volume:
6,873,514
5,857,705
  • Prev Close
    61.09
  • Today's Open
    61.00
  • Day's Range
    60.81-61.71
  • Avg Vol (10-day)
    6.9M
  • Last (time)
    4:00p ET 08/08/22
  • Last (size)
    41
  • 52-Wk Range
    57.17 - 74.12
    LowHigh
  • (12/30/21 - 06/14/22)
    7.76%
  • 19.2%
  • Market Cap
    77.3B
  • Shares Outstanding
    1.3B
  • 3.28
  • 18.63x
  • $2.92/4.78%
  • Ex-dividend Date
    09/14/22
  • Dividend Pay Date
    09/29/22
  • 0.4
  • 79.24
  • (% of float 07/15/22)
    1.32

Latest News

August 08, 2022
4:55 pm ET
MarketWatch
August 05, 2022
4:55 pm ET
MarketWatch
August 04, 2022
4:55 pm ET
MarketWatch
8:00 am ET
BusinessWire
August 03, 2022
4:55 pm ET
MarketWatch
August 02, 2022
4:55 pm ET
MarketWatch
4:01 pm ET
BusinessWire
August 01, 2022
4:55 pm ET
MarketWatch
8:47 am ET
Zacks
8:47 am ET
Zacks
July 29, 2022
4:55 pm ET
MarketWatch
July 28, 2022
4:55 pm ET
MarketWatch
1:30 pm ET
BusinessWire
July 27, 2022
4:55 pm ET
MarketWatch
7:00 am ET
BusinessWire
July 26, 2022
4:55 pm ET
MarketWatch
July 25, 2022
4:55 pm ET
MarketWatch
July 22, 2022
4:55 pm ET
MarketWatch
9:42 am ET
BusinessWire
7:06 am ET
BusinessWire
July 21, 2022
4:55 pm ET
MarketWatch
8:30 am ET
BusinessWire
July 20, 2022
4:55 pm ET
MarketWatch
12:30 pm ET
BusinessWire
July 19, 2022
9:00 am ET
BusinessWire
July 15, 2022
4:55 pm ET
MarketWatch
July 14, 2022
4:55 pm ET
MarketWatch
7:05 am ET
MarketWatch
July 13, 2022
4:57 pm ET
MarketWatch
8:09 am ET
MarketWatch
July 12, 2022
4:59 pm ET
MarketWatch
4:05 pm ET
BusinessWire
8:30 am ET
BusinessWire
July 11, 2022
4:55 pm ET
MarketWatch
July 08, 2022
4:55 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.